ArticleMolecular diagnosis & therapy2020

Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants.

Valerie Pestinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.